Compound Detail
CHEMBL3590106
ULIXERTINIB 🧪 Phase II
Enter ChEMBL ID:
Free Research Context
This compound will appear in recent viewed items on the research home for this browser.
Research home
View demo workspace
🧪 Phase II
Basic Information
| ChEMBL ID | CHEMBL3590106 |
| Name | ULIXERTINIB |
| Phase | Phase II |
| Structure Type | MOL |
| InChI Key | KSERXGMCDHOLSS-LJQANCHMSA-N |
13
Targets
26
Activities
3
Assay Types
8
PK Parameters
20
Publications
4
Known Names
6
Indications
2
Mechanisms
Molecular Properties
433.3
MW (Da)
4.67
ALogP
4
HBA
4
HBD
90.0
PSA (Ų)
0.44
QED
0
Ro5 Violations
7
Rot. Bonds
Drug Information
| Molecule Type | Small molecule |
| Chirality | Single Enantiomer |
Mechanism of Action
| Mechanism | Action Type | Target | Direct | Efficacy |
|---|---|---|---|---|
| MAP kinase ERK1 inhibitor | INHIBITOR | Mitogen-activated protein kinase 3 | ✓ | ✓ |
| MAP kinase ERK2 inhibitor | INHIBITOR | Mitogen-activated protein kinase 1 | ✓ | ✓ |
Indications
Neoplasms Uveal Melanoma Leukemia, Myeloid, Acute Myelodysplastic Syndromes Pancreatic Neoplasms Paraganglioma
Activity Summary
IC50 19 meas. best 10.52
Kd 6 meas. best 9.5
Ki 1 meas. best 10.4
Target Activity Profile
| Target | Type | Best pChEMBL | Mean pChEMBL | Best (nM) | # Data |
|---|---|---|---|---|---|
| Mitogen-activated protein kinase 1 CHEMBL4040 | IC50 | 10.52 | 7.356 | 0.0 | 5 |
| Mitogen-activated protein kinase 1 CHEMBL4040 | Ki | 10.4 | 10.4 | 0.0 | 1 |
| Mitogen-activated protein kinase 1 CHEMBL4040 | Kd | 9.5 | 8.08 | 0.3 | 3 |
| COLO 205 CHEMBL614561 | IC50 | 6.99 | 6.99 | 102.7 | 1 |
| Mitogen-activated protein kinase; ERK1/ERK2 CHEMBL1907606 | IC50 | 6.85 | 6.3933 | 140.0 | 3 |
| Mitogen-activated protein kinase 3 CHEMBL3385 | Kd | 6.8 | 6.8 | 160.0 | 1 |
| A-375 CHEMBL613859 | IC50 | 6.75 | 6.75 | 180.0 | 1 |
| Unchecked CHEMBL612545 | IC50 | 6.52 | 6.215 | 300.0 | 2 |
| SK-CO-1 CHEMBL1075576 | IC50 | 6.45 | 6.45 | 356.0 | 1 |
| Serine/threonine-protein kinase TAO1 CHEMBL5261 | Kd | 6.41 | 6.41 | 388.0 | 1 |
| BaF3 CHEMBL614524 | IC50 | 6.33 | 5.6833 | 468.0 | 3 |
| SW-620 CHEMBL612262 | IC50 | 6.3 | 6.3 | 499.0 | 1 |
| ASPC1 CHEMBL612588 | IC50 | 6.07 | 6.07 | 849.0 | 1 |
| NCI-H23 CHEMBL614997 | IC50 | 6.0 | 6.0 | 1000.0 | 1 |
| Serine/threonine-protein kinase D2 CHEMBL4900 | Kd | 5.2 | 5.2 | 6336.0 | 1 |
Pharmacokinetic Data
| Parameter | Value | Units | Species |
|---|---|---|---|
| AUC | 113936.0 | ng.hr.mL-1 | Mus musculus |
| AUC | 48848.0 | ng.hr.mL-1 | Mus musculus |
| Cmax | 32.28 | ug.mL-1 | Mus musculus |
| Cmax | 12.99 | ug.mL-1 | Mus musculus |
| Ka | 7.5 | 10'-5/M/s | Homo sapiens |
| Ka | 1.3 | 10'-6/M/s | Homo sapiens |
| T1/2 | 0.03333 | hr | Homo sapiens |
| T1/2 | 0.5833 | hr | Homo sapiens |
Activity Data Samples
Top measurements by pChEMBL value
Literature References
Data from ChEMBL 36 via Core Engine